Skip to content

Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound

Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07051369
Enrollment
150
Registered
2025-07-04
Start date
2025-03-17
Completion date
2026-02-28
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis, Liver

Brief summary

Portal hypertension is a common and serious complication of liver cirrhosis, often leading to life-threatening conditions such as variceal bleeding, ascites, and hepatic encephalopathy.

Detailed description

Early detection and management are crucial for improving patient outcomes. While invasive methods such as hepatic venous pressure gradient (HVPG) measurement are the gold standard for diagnosis, they are costly and not widely available. Ultrasound, particularly Doppler imaging, offers a non-invasive, cost- effective alternative for assessing portal hypertension.This study aims to determine the frequency of portal hypertension among patients with cirrhotic liver using ultrasound.

Interventions

DIAGNOSTIC_TESTPortal Hypertension diagnostics

his study aims to determine the frequency of portal hypertension among patients with cirrhotic liver using ultrasound.A cross-sectional study will be conducted at Sheikh Zaid Medical College and Hospital, Rahim Yar Khan,

Sponsors

Superior University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients with a history of chronic liver disease (CLD) will be included. * Both male and female patients will be included.

Exclusion criteria

* Non-cirrhotic liver patients * Non-cooperative patients.Patients who do not provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Ultrasound Parameter Response12 Monthsthis questioner will take the data from the ultrasound values having liver chirosis

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026